1. Home
  2. NVAX vs WLFC Comparison

NVAX vs WLFC Comparison

Compare NVAX & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • WLFC
  • Stock Information
  • Founded
  • NVAX 1987
  • WLFC 1985
  • Country
  • NVAX United States
  • WLFC United States
  • Employees
  • NVAX N/A
  • WLFC N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • WLFC Industrial Specialties
  • Sector
  • NVAX Health Care
  • WLFC Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • WLFC Nasdaq
  • Market Cap
  • NVAX 1.3B
  • WLFC 1.2B
  • IPO Year
  • NVAX 1995
  • WLFC 1996
  • Fundamental
  • Price
  • NVAX $6.66
  • WLFC $138.30
  • Analyst Decision
  • NVAX Buy
  • WLFC
  • Analyst Count
  • NVAX 6
  • WLFC 0
  • Target Price
  • NVAX $17.83
  • WLFC N/A
  • AVG Volume (30 Days)
  • NVAX 8.5M
  • WLFC 42.3K
  • Earning Date
  • NVAX 05-08-2025
  • WLFC 05-06-2025
  • Dividend Yield
  • NVAX N/A
  • WLFC 0.74%
  • EPS Growth
  • NVAX N/A
  • WLFC 66.69
  • EPS
  • NVAX 2.97
  • WLFC 14.50
  • Revenue
  • NVAX $1,254,962,000.00
  • WLFC $594,146,000.00
  • Revenue This Year
  • NVAX N/A
  • WLFC $16.35
  • Revenue Next Year
  • NVAX N/A
  • WLFC $10.53
  • P/E Ratio
  • NVAX $2.24
  • WLFC $9.30
  • Revenue Growth
  • NVAX 25.92
  • WLFC 35.29
  • 52 Week Low
  • NVAX $4.43
  • WLFC $55.31
  • 52 Week High
  • NVAX $23.86
  • WLFC $235.43
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.25
  • WLFC 39.68
  • Support Level
  • NVAX $5.82
  • WLFC $124.90
  • Resistance Level
  • NVAX $6.61
  • WLFC $158.72
  • Average True Range (ATR)
  • NVAX 0.53
  • WLFC 6.80
  • MACD
  • NVAX 0.02
  • WLFC 0.23
  • Stochastic Oscillator
  • NVAX 42.21
  • WLFC 32.64

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

Share on Social Networks: